|
OAS3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69420033557799E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67128549783047E-12 |
| Normal-vs-Stage2 |
2.000400E-04 |
| Normal-vs-Stage3 |
3.94169999973215E-08 |
| Normal-vs-Stage4 |
2.96900004581602E-09 |
| Stage1-vs-Stage2 |
1.460770E-01 |
| Stage1-vs-Stage3 |
6.230200E-01 |
| Stage1-vs-Stage4 |
1.581820E-01 |
| Stage2-vs-Stage3 |
1.195780E-01 |
| Stage2-vs-Stage4 |
2.390200E-02 |
| Stage3-vs-Stage4 |
4.568800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97619698383278E-14 |
| Normal-vs-AfricanAmerican |
2.455400E-03 |
| Normal-vs-Asian |
7.610200E-02 |
| Caucasian-vs-AfricanAmerican |
3.381600E-02 |
| Caucasian-vs-Asian |
4.390600E-01 |
| AfricanAmerican-vs-Asian |
2.328600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.18809472949533E-12 |
| Normal-vs-Female |
2.71893618730701E-13 |
| Male-vs-Female |
1.530010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.744500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.6304735339645E-12 |
| Normal-vs-Age(61-80Yrs) |
2.81330514440015E-12 |
| Normal-vs-Age(81-100Yrs) |
6.846300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.463200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.587400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.147200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.318600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.763200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.847600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.47660000000094E-05 |
| Normal-vs-Grade 2 |
9.5723429183181E-13 |
| Normal-vs-Grade 3 |
1.00829999905017E-09 |
| Normal-vs-Grade 4 |
4.2869999994366E-08 |
| Grade 1-vs-Grade 2 |
5.118600E-01 |
| Grade 1-vs-Grade 3 |
4.962400E-01 |
| Grade 1-vs-Grade 4 |
8.890800E-01 |
| Grade 2-vs-Grade 3 |
6.038000E-01 |
| Grade 2-vs-Grade 4 |
1.889850E-01 |
| Grade 3-vs-Grade 4 |
9.917700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.94584365182027E-12 |
| Normal-vs-ccB subtype |
7.37020000585176E-10 |
| ccA subtype-vs-ccB subtype |
7.905200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.68800562206206E-12 |
| Normal-vs-N1 |
7.975300E-03 |
| N0-vs-N1 |
2.565600E-01 |
|
|
